Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

NCT00477048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

IDV Associated Nephrotoxicity

Interventions

DRUG: Saquinavir

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]
[object Object]